Roivant Sciences Ltd. (ROIV)

NASDAQ: ROIV · USD

$37.1

+0.57 (+1.6%)· Recorded snapshot

Market cap	26.8B
Revenue (ttm)	7.5M
Net income (ttm)	-266.3M
EPS (ttm)	-$0.49
Shares out	722.3M
Volume	3,394,577
Beta	1.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.5M
Net income (ttm): -266.3M
EPS (ttm): -$0.49
Market cap: 26.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-8.5

P25 n/aP50 n/aP75 n/a

ROIC-117.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ROIV indicators

Market & fundamental data

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001635088
Company name	Roivant Sciences Ltd.
Country	United Kingdom
Country code	US
CUSIP number	G76279101
Earnings date	2026-11-09
Earnings time	bmo
Employees	721
Employees change	-29
Employees growth	-3.87%
Enterprise value	$23.1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	2014
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	BMG762791017
Last 10-K release date	2026-05-20
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$26.8B
Market cap category	Large-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$37.11
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ROIV
Website	https://roivant.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.31%
EV/Sales	3,031.35x
FCF / EV yield	-3.6%
FCF yield	-3.09%
Forward EV/Sales	218.1x
Forward P/S	253.77x
P/B ratio	6.24x
P/S ratio	3,527.22x
Price / tangible book value	6.28x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-17,875.42%
Pretax margin	-3,848.65%
Profit per employee	$-369,283
Revenue per employee	$10,447
ROA	-16.28%
ROA (5Y)	-15.12%
ROCE	-26.8%
ROE	-8.52%
ROE (5Y)	-0.11%
ROIC	-117.33%
SBC / revenue	4,611.38%
Tax / revenue	1,655.89%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	-67.58%
Revenue growth (Q)	-33.55%
Revenue growth (QoQ)	-42.78%
Revenue growth 3Y	-50.32%
Revenue growth 5Y	-24.13%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-4.6M
Depreciation and amortization	$2.9M
EBIT	$-1.3B
EBITDA	$-1.3B
EPS	$-0.49
FCF per share	$-1.14
Financing cash flow	$140.5M
Free cash flow	$-821.1M
Free cash flow minus SBC	$-1.2B
Gross profit	$-723.9M
Income taxes	$124.7M
Investing cash flow	$684.6M
Net cash flow	$11.9M
Net income	$-266.3M
Operating cash flow minus SBC	$-1.2B
Operating income	$-1.3B
Revenue	$7.5M
Stock-based compensation	$347.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	23.81
Book value per share	$5.86
Debt / equity	0.02
Long-term assets	$564.4M
Long-term liabilities	$101M
Net cash (debt)	$3.7B
Net cash / market cap	14.06%
Net cash growth	-15.18%
Net debt / equity	-0.76
Piotroski F-Score	0
Property, plant and equipment	$90.2M
Shareholders' equity	$4.9B
Tangible book value	$4.2B
Tangible book value per share	$5.86
Total assets	$5.3B
Total cash	$3.8B
Total debt	$107.2M
Total liabilities	$384.6M
WACC	10.27%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$4.7B
Current liabilities	$283.6M
Current ratio	16.72
Net working capital	$628.8M
Quick ratio	13.62
Working capital	$4.5B
Working capital turnover	0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.06%
Dividend yield	0%
Shareholder yield	1.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$33.11
1D price change	1.56%
1M price change	2.65%
1M total return	2.65%
1W price change	5.24%
1W total return	5.24%
1Y price change	95.38%
1Y return CAGR	95.47%
1Y total return	95.38%
20-day SMA	$35.29
200-day SMA	$31.36
3M price change	5.85%
3M total return	5.85%
3Y price change	338.54%
3Y return CAGR	63.67%
3Y total return	338.54%
50-day SMA	$36.64
50-day SMA vs 200-day SMA	50over200
52-week high	$42.50
52-week high date	2026-09-08
52-week low	$18.32
52-week low date	2025-10-29
5Y price change	374.81%
5Y return CAGR	36.56%
5Y total return	374.81%
6M price change	31.96%
6M total return	31.96%
All-time high	$42.50
All-time high date	2026-09-08
All-time low	$2.52
All-time low date	2022-05-12
Average true range (ATR)	$1.35
Average volume	6.5M
Beta (1Y)	0.51
Beta (2Y)	0.82
Beta (5Y)	1.1
Change from 52-week high	-12.68%
Change from 52-week low	102.57%
Change from all-time high	-13.53%
Change from all-time low	1,358.33%
Change from open	2.12%
Day's gap	-0.55%
Dollar volume	$126M
High price	$37.12
Low price	$36.29
Monthly RSI	83.72
Open price	$36.34
Position in 52-week range	98.8%
Premarket change	-0.38%
Premarket close	$36.54
Premarket price	$36.40
Premarket volume	17.7K
Previous close	$36.54
Price vs 150-day SMA	10.99%
Price vs 20-day SMA	4.14%
Price vs 200-day SMA	17.17%
Price vs 50-day SMA	0.31%
Relative volume	0.53
RSI	54.48
Sharpe ratio	1.57
Sharpe ratio (3Y)	1.35
Sharpe ratio (5Y)	0.83
Sortino ratio	3.45
Sortino ratio (3Y)	2.63
Sortino ratio (5Y)	1.52
Volume	3.4M
Weekly RSI	58.93
YTD price change	69.36%
YTD total return	69.36%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	582.2M
Float percentage	80.6%
Shares change (QoQ)	-11.27%
Shares change (YoY)	-1.06%
Shares held by insiders	18.7%
Shares held by institutions	77.76%
Shares outstanding	722.3M
Short % of float	6.75%
Short % of shares	5.44%
Short ratio	3.8 days

Deeper analysis on ROIV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ROIV report

Is a complete ROIV research report available?

No complete published report is available for Roivant Sciences Ltd. (ROIV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Roivant Sciences Ltd. (ROIV)

Price

Financial snapshot

Fair-value bridge

Latest news · ROIV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ROIV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ROIV

Frequently asked questions